Quick Summary
Pelargonium sidoides is a medicinal plant widely studied for its potential benefits in acute respiratory tract infections (ARTIs), including acute bronchitis, common cold, acute tonsillopharyngitis, and rhinosinusitis. Its standardized extract EPs 7630 has demonstrated antimicrobial, immunomodulatory, antiviral, and antiadhesive properties. Clinical trials and meta-analyses suggest it may reduce symptom severity and duration in respiratory infections, particularly in children and adults. It is generally well tolerated with a favorable safety profile and low incidence of adverse effects. However, evidence quality varies and larger, high-quality trials are needed to confirm these findings.
What is it?
Pelargonium sidoides is a plant species native to South Africa, traditionally used for medicinal purposes. Extracts from its roots, especially the standardized preparation EPs 7630, are commonly utilized in herbal remedies targeting respiratory infections.
Traditional Uses
Historically, Pelargonium sidoides has been used in traditional medicine systems to support respiratory health and treat symptoms associated with colds, bronchitis, sinus infections, and sore throats.
Active Compounds
The root extract EPs 7630 contains a combination of bioactive constituents including polyphenols, coumarins, and proanthocyanidins. These compounds are thought to contribute to the plant’s antimicrobial, antiviral, and immunomodulatory effects.
Potential Benefits with Evidence Levels
- May reduce severity and duration of acute bronchitis symptoms in adults and children: Moderate quality evidence from multiple randomized controlled trials (RCTs) and meta-analyses.
- Potential efficacy for common cold symptom relief including cough reduction and quality of life improvement: Moderate quality evidence from randomized placebo-controlled trials and meta-analyses.
- May alleviate symptoms of acute tonsillopharyngitis and acute rhinosinusitis: Low to very low quality evidence from randomized controlled trials.
- Demonstrated antiviral and immunomodulatory effects: Evidence from preclinical and mechanistic studies, supported by some clinical data.
- Appears beneficial as an adjuvant treatment in pediatric acute respiratory infections: Clinical trials including randomized controlled studies showing symptom reduction and safety.
Side Effects
Pelargonium sidoides extract is generally well tolerated. Mild and transient adverse effects may occur, including:
- Dizziness
- Drowsiness
- Headache
- Gastrointestinal complaints such as nausea
- Unpleasant taste (rarely reported)
No evidence of liver toxicity has been observed in recent short-term safety studies at recommended doses. Serious adverse effects are rare or not reported when used alone.
Drug Interactions
There is limited clinical data on specific drug interactions. Reviews of herbal medicinal products suggest serious interactions are uncommon, but caution is advised when Pelargonium sidoides is used concurrently with anticoagulants or other critical medications. Specific interaction studies with this herb are lacking.
Who Should Avoid It
Due to limited evidence, Pelargonium sidoides should be used cautiously or avoided in:
- Individuals with known allergies to the herb
- People with severe hepatic or renal impairment (data lacking)
- Pregnant or breastfeeding women, unless under medical supervision due to insufficient safety data
Evidence Limitations
- Many clinical trials vary in quality, ranging from low to moderate.
- Heterogeneity in product preparations and dosing complicates the generalizability of findings.
- Limited long-term safety data and post-marketing surveillance are available.
- Few large-scale, double-blind RCTs especially in special populations like pregnant women.
- Evidence for some respiratory conditions remains preliminary or very limited.
- Potential publication bias and predominance of studies conducted in certain geographic regions.
- Insufficient mechanistic data linking biological effects directly to clinical outcomes.
References
- Pelargonium sidoides for acute bronchitis: a systematic review and meta-analysis (PMID: 18222667)
- Pelargonium sidoides extract EPs 7630 for treating acute respiratory tract infections (PMID: 24146345)
- Phytotherapy for acute respiratory tract infections in children: a comprehensive review (PMID: 40376625)
- Phytotherapeutic, Homeopathic Interventions and Bee Products for Pediatric Infections: A Scoping Review (PMID: 41097214)
- Short-term Liver Safety of Pelargonium sidoides Root: A Post-authorization Safety Study (PMID: 41890334)
- Herbal Medicines for Rhinosinusitis: A Systematic Review and Network Meta-analysis (PMID: 36609950)
- Multiple mechanisms enable broad-spectrum activity of EPs 7630 (PMID: 39469622)
- Real-world data analysis of EPs 7630 benefits in acute bronchitis (PMID: 41031167)
- Adjuvant Treatment with Pelargonium sidoides in Pediatric Tonsillopharyngitis (PMID: 40150627)
Last Reviewed
June 2024
Disclaimer: This page provides information based on current scientific evidence and is intended for educational purposes only. It does not provide medical advice and should not replace consultation with a qualified healthcare professional. Always consult a healthcare provider before starting any new treatment, especially if you have existing health conditions or are taking other medications.